139 related articles for article (PubMed ID: 23510308)
1. Protected by nature? Effects of strenuous physical exercise on FVIII activity in moderate and mild haemophilia A patients: a pilot study.
Groen WG; den Uijl IE; van der Net J; Grobbee DE; de Groot PG; Fischer K
Haemophilia; 2013 Jul; 19(4):519-23. PubMed ID: 23510308
[TBL] [Abstract][Full Text] [Related]
2. Effects of moderate-intensity physical exercise on pharmacokinetics of factor VIII and von Willebrand factor in young adults with severe haemophilia A: a pilot study.
Zourikian N; Merlen C; Bonnefoy A; St-Louis J; Rivard GE
Haemophilia; 2016 May; 22(3):e177-83. PubMed ID: 26988074
[TBL] [Abstract][Full Text] [Related]
3. Response of factor VIII/von Willebrand factor to intranasal DDAVP in healthy subjects and mild haemophiliacs (with observations in patients with combined deficiency of factors V and VIII).
Garcia VV; Silva IA; Borrasca AL
Thromb Haemost; 1982 Aug; 48(1):91-3. PubMed ID: 6813999
[TBL] [Abstract][Full Text] [Related]
4. Impact of aerobic exercise on haemostatic indices in paediatric patients with haemophilia.
Kumar R; Bouskill V; Schneiderman JE; Pluthero FG; Kahr WH; Craik A; Clark D; Whitney K; Zhang C; Rand ML; Carcao M
Thromb Haemost; 2016 Jun; 115(6):1120-8. PubMed ID: 26917411
[TBL] [Abstract][Full Text] [Related]
5. [Does FVIII-activity increase with age in patients with haemophilia A and carriers of haemophilia A?].
Delbrück C; Haferland I; Scholz K; Asmelash G; Makki V; Müller S; Krekeler S; Alesci S; Miesbach W
Hamostaseologie; 2011 Nov; 31 Suppl 1():S24-8. PubMed ID: 22057150
[TBL] [Abstract][Full Text] [Related]
6. Normalization of factor VIII levels in a patient with mild haemophilia A during a 35-year period.
Mainwaring CJ; Evans J; Chana J; Lewis H
Haemophilia; 2006 Nov; 12(6):668-71. PubMed ID: 17083519
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of three automated chromogenic FVIII kits for the diagnosis of mild discrepant haemophilia A.
Rodgers SE; Duncan EM; Sobieraj-Teague M; Lloyd JV
Int J Lab Hematol; 2009 Apr; 31(2):180-8. PubMed ID: 18190586
[TBL] [Abstract][Full Text] [Related]
8. DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor.
Casonato A; Dannhauser D; Pontara E; Bertomoro A; Orazi B; Santarossa L; Zerbinati P; Girolami A
Blood Coagul Fibrinolysis; 1996 Jul; 7(5):549-53. PubMed ID: 8874865
[TBL] [Abstract][Full Text] [Related]
9. DDAVP responsiveness in children with mild or moderate haemophilia A correlates with age, endogenous FVIII:C level and with haemophilic genotype.
Seary ME; Feldman D; Carcao MD
Haemophilia; 2012 Jan; 18(1):50-5. PubMed ID: 21592259
[TBL] [Abstract][Full Text] [Related]
10. The mild phenotype in severe hemophilia A with Arg1781His mutation is associated with enhanced binding affinity of factor VIII for factor X.
Yada K; Nogami K; Wakabayashi H; Fay PJ; Shima M
Thromb Haemost; 2013 Jun; 109(6):1007-15. PubMed ID: 23467620
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiological Mechanisms of Endogenous FVIII Release following Strenuous Exercise in Non-severe Haemophilia: A Review.
Venema CL; Schutgens REG; Fischer K
Thromb Haemost; 2017 Dec; 117(12):2237-2242. PubMed ID: 29212111
[TBL] [Abstract][Full Text] [Related]
12. Moderate-intensity exercise improves the thromboelastography coagulation index in children with severe hemophilia A.
Li KX; Xiao J; Zhao YQ; Shou WL; Chen M; Li Z; Poon MC; Han HJ
Blood Coagul Fibrinolysis; 2016 Oct; 27(7):797-803. PubMed ID: 26656895
[TBL] [Abstract][Full Text] [Related]
13. Frequency of factor VIII (FVIII) inhibitor in haemophilia A.
Borhany M; Kumari M; Shamsi T; Naz A; Farzana T
J Coll Physicians Surg Pak; 2012 May; 22(5):289-93. PubMed ID: 22538032
[TBL] [Abstract][Full Text] [Related]
14. DDAVP challenge tests in boys with mild/moderate haemophilia A.
Revel-Vilk S; Blanchette VS; Sparling C; Stain AM; Carcao MD
Br J Haematol; 2002 Jun; 117(4):947-51. PubMed ID: 12060135
[TBL] [Abstract][Full Text] [Related]
15. Intranasal DDAVP induced increases in plasma von Willebrand factor alter the pharmacokinetics of high-purity factor VIII concentrates in severe haemophilia A patients.
Deitcher SR; Tuller J; Johnson JA
Haemophilia; 1999 Mar; 5(2):88-95. PubMed ID: 10215955
[TBL] [Abstract][Full Text] [Related]
16. Mild haemophilia: a disease with many faces and many unexpected pitfalls.
Peerlinck K; Jacquemin M
Haemophilia; 2010 Jul; 16 Suppl 5():100-6. PubMed ID: 20590864
[TBL] [Abstract][Full Text] [Related]
17. Desmopressin in haemophilia: The need for a standardised clinical response and individualised test regimen.
Stoof SCM; Schütte LM; Leebeek FWG; Cnossen MH; Kruip MJHA
Haemophilia; 2017 Nov; 23(6):861-867. PubMed ID: 28636264
[TBL] [Abstract][Full Text] [Related]
18. Risk of inhibitor development in mild haemophilia A increases with age.
Mauser-Bunschoten EP; Den Uijl IE; Schutgens RE; Roosendaal G; Fischer K
Haemophilia; 2012 Mar; 18(2):263-7. PubMed ID: 21851507
[TBL] [Abstract][Full Text] [Related]
19. Analysis of low frequency bleeding data: the association of joint bleeds according to baseline FVIII activity levels.
den Uijl IE; Fischer K; Van Der Bom JG; Grobbee DE; Rosendaal FR; Plug I
Haemophilia; 2011 Jan; 17(1):41-4. PubMed ID: 20825504
[TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis of differences in annual factor VIII utilization among haemophilia A patients.
Epstein J; Xiong Y; Woo P; Li-McLeod J; Spotts G
Haemophilia; 2012 Mar; 18(2):187-92. PubMed ID: 21883704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
